| Literature DB >> 23937984 |
Li Zhou1, Jian-Hua You, Wen Wu, Jun-Min Li, Zhi-Xiang Shen, Ai-Hua Wang.
Abstract
We presented our experience in chronic myeloid leukemia (CML) patients who conceived children and/or became pregnant while receiving tyrosine kinase inhibitor (TKI). Among 7 male patients, 7 pregnancies resulted in the birth of 7 healthy babies. Among 18 female patients, 8 ended in elective abortion; 3 had spontaneous abortion, and 7 carried to term, resulting in the birth of 8 healthy babies. All children have normal growth and development. All patients remain in TKI therapy and in good response. It is suggested that female patients are advised to practice adequate contraception. No special precautions apply for male patients receiving TKI.Entities:
Keywords: Chronic myeloid leukemia; Imatinib; Nilotinib; Pregnancy
Mesh:
Substances:
Year: 2013 PMID: 23937984 DOI: 10.1016/j.leukres.2013.07.020
Source DB: PubMed Journal: Leuk Res ISSN: 0145-2126 Impact factor: 3.156